2020
Having a Primary Care Provider is the Strongest Predictor of Successful Follow-up of Participants in a Clinical Trial
Friedman S, Cunningham C, Lin J, Haramati L, Levsky J. Having a Primary Care Provider is the Strongest Predictor of Successful Follow-up of Participants in a Clinical Trial. The Journal Of The American Board Of Family Medicine 2020, 33: 431-439. PMID: 32430375, DOI: 10.3122/jabfm.2020.03.190018.Peer-Reviewed Original ResearchConceptsPrimary care physiciansClinical trialsCare providersHigher Charlson Comorbidity Index scoresMultivariate analysisCharlson Comorbidity Index scoreProspective randomized control trialBivariate analysisComorbidity Index scoreChest pain patientsPrimary care providersHealth care providersRandomized control trialLow socioeconomic statusSocioeconomic status scoresHealth care systemPain patientsPatient characteristicsCare physiciansInsurance statusStatus scoreMedical historyFollow-upControl trialIndex score
2018
Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community
Su C, Bhargava A, Shah C, Halmos B, Gucalp R, Packer S, Ohri N, Haramati L, Perez-Soler R, Cheng H. Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community. Clinical Lung Cancer 2018, 19: e767-e773. PMID: 29937386, DOI: 10.1016/j.cllc.2018.05.019.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAgedCarcinoma, Squamous CellCombined Modality TherapyDecision Support TechniquesEarly Detection of CancerFemaleFollow-Up StudiesHumansLung NeoplasmsMaleMedically Underserved AreaMiddle AgedPrognosisRetrospective StudiesSmall Cell Lung CarcinomaSurvival RateTomography, X-Ray ComputedUrban PopulationConceptsUnited States Preventative Services Task Force guidelinesPrimary lung cancerTask Force guidelinesLung cancerScreening TrialMortality differencesPrimary care provider statusScreen-detected lung cancersNational Lung Screening TrialLung cancer-related mortalityLung Cancer Screening TrialActive smoking statusTime of diagnosisCancer Screening TrialCancer-related mortalityUnderserved communitiesUrban underserved communitiesLCS eligibilityCause mortalityPatient characteristicsProspective trialCurative treatmentSmoking statusSurgical managementCox regression
2017
Performance of a simple robust empiric timing protocol for CT pulmonary angiography
Hsu K, Levsky J, Haramati L, Gohari A. Performance of a simple robust empiric timing protocol for CT pulmonary angiography. Clinical Imaging 2017, 48: 17-21. PMID: 29024836, DOI: 10.1016/j.clinimag.2017.09.006.Peer-Reviewed Original ResearchConceptsPulmonary arteryLower radiation exposureTiming groupsRadiation exposureBolus groupAortic enhancementCT pulmonary angiographySimilar mean ageResults of CTPAConsecutive CTPAsEmpiric protocolPatient characteristicsPulmonary angiographyRetrospective reviewMean ageBolus protocolPositivity rateHigh diagnostic qualityArteryDiagnostic quality imagesBolus methodCTPATiming bolusProtocol changesAorta